{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T08:01:35Z","timestamp":1781164895651,"version":"3.54.1"},"reference-count":102,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>The coexistence of cancer and severe aortic stenosis (AS) is increasing as a result of population aging and substantial improvements in cancer survival. Transcatheter aortic valve implantation (TAVI) has transformed the management of AS; however, patients with active malignancy or a history of cancer remain markedly under-represented in pivotal randomized trials. This under-representation has resulted in persistent uncertainty regarding patient selection, risk stratification, and the expected benefit of TAVI in this growing and clinically heterogeneous population. This review provides a comprehensive and contemporary synthesis of the evidence on TAVI in patients with cancer, integrating cardiovascular (CV), oncologic, and geriatric perspectives. Available data on epidemiological overlap, cancer-specific procedural challenges, and short- and long-term outcomes following TAVI are critically examined, with particular emphasis on distinctions between active cancer and cancer survivorship. Key modifiers of risk and benefit\u2014including prior thoracic radiotherapy, competing thrombotic and bleeding risk, immunosuppression, frailty, sarcopenia, and nutritional status\u2014are discussed in detail. Limitations of conventional surgical risk scores in oncology populations are highlighted, underscoring the need for individualized assessment beyond traditional CV metrics. Across registries and meta-analyses, TAVI is associated with high procedural success and comparable short-term outcomes in patients with and without cancer. Excess mortality observed during mid- and long-term follow-up is driven predominantly by non-CV causes related to malignancy rather than valve-related complications. Importantly, patients with cancer in remission demonstrate outcomes similar to those of non-cancer populations, whereas prognosis in active cancer is strongly influenced by disease stage, biology, and competing risks. Overall, cancer diagnosis alone should not preclude consideration of TAVI. Optimal management requires multidisciplinary, goal-oriented decision-making that integrates oncologic prognosis, functional status, and patients\u2019 priorities. As cancer survivorship continues to expand, prospective studies, integrated risk stratification tools, and closer alignment between cardio-oncology and structural heart programs are essential to guide evidence-based and equitable care.<\/jats:p>","DOI":"10.3390\/medicina62061139","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T06:57:17Z","timestamp":1781161037000},"page":"1139","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transcatheter Aortic Valve Implantation in Cancer Patients: A Contemporary Review of the Specific Challenges, the Outcomes, Risk Stratification, and Decision-Making"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9533-6951","authenticated-orcid":false,"given":"Kalliopi","family":"Keramida","sequence":"first","affiliation":[{"name":"Cardiology Department, General Anticancer Oncological Hospital, Agios Savvas, 11522 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Mavraganis","sequence":"additional","affiliation":[{"name":"Department of Clinical Therapeutics, Alexandra Hospital, School of Medical, National and Kapodistrian University of Athens, 80 Vas. Sofias Str., 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantina","family":"Masoura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, General Hospital of Athens \u201cLaiko\u201d, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0706-4424","authenticated-orcid":false,"given":"Konstantinos","family":"Aznaouridis","sequence":"additional","affiliation":[{"name":"Department of Cardiology, \u201cHippokration\u201d General Hospital of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2445-0879","authenticated-orcid":false,"given":"Vasiliki","family":"Androutsopoulou","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, University Hospital of Larissa, 41110 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Tsioufis","sequence":"additional","affiliation":[{"name":"Department of Cardiology, \u201cHippokration\u201d General Hospital of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1161\/01.CIR.0000047200.36165.B8","article-title":"Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: First human case description","volume":"106","author":"Cribier","year":"2002","journal-title":"Circulation"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1001\/jamacardio.2021.2534","article-title":"Guideline Update on Indications for Transcatheter Aortic Valve Implantation Based on the 2020 American College of Cardiology\/American Heart Association Guidelines for Management of Valvular Heart Disease","volume":"6","author":"Sundt","year":"2021","journal-title":"JAMA Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1093\/eurheartj\/ehaf194","article-title":"2025 ESC\/EACTS Guidelines for the management of valvular heart disease: Developed by the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"46","author":"Praz","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Santangelo, G., Moscardelli, S., Barbieri, L., Faggiano, A., Carugo, S., and Faggiano, P. (2023). Aortic Valve Stenosis and Cancer: Problems of Management. J. Clin. Med., 12.","DOI":"10.20944\/preprints202308.0404.v1"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11912-017-0601-x","article-title":"Cancer as a Risk Factor for Cardiovascular Disease","volume":"19","author":"Giza","year":"2017","journal-title":"Curr. Oncol. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.xjon.2024.10.024","article-title":"Outcomes of surgical valve replacements for radiation-induced valvulopathy","volume":"23","author":"Abruzzo","year":"2025","journal-title":"JTCVS Open"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa1103510","article-title":"Transcatheter versus surgical aortic-valve replacement in high-risk patients","volume":"364","author":"Smith","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients","volume":"374","author":"Leon","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients","volume":"380","author":"Mack","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/S0140-6736(15)60290-2","article-title":"5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): A randomised controlled trial","volume":"385","author":"Kapadia","year":"2015","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jacc.2015.05.017","article-title":"2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement","volume":"66","author":"Reardon","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/joic.12458","article-title":"Impact of active cancer disease on the outcome of patients undergoing transcatheter aortic valve replacement","volume":"31","author":"Mangner","year":"2018","journal-title":"J. Interv. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s40959-024-00256-8","article-title":"Outcomes of patients with active cancer after transcatheter aortic valve replacement: An updated meta-analysis","volume":"10","author":"Felix","year":"2024","journal-title":"Cardio-Oncology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e001131","DOI":"10.1136\/openhrt-2019-001131","article-title":"Transcatheter aortic valve replacement in patients with severe aortic stenosis and active cancer: A systematic review and meta-analysis","volume":"7","author":"Bendary","year":"2020","journal-title":"Open Heart"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e70121","DOI":"10.1002\/clc.70121","article-title":"Clinical Outcomes and Prognostic Implications of TAVR in Patients With Active Cancer: A Meta-Analysis","volume":"48","author":"Saberian","year":"2025","journal-title":"Clin. Cardiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e002573","DOI":"10.1136\/openhrt-2023-002573","article-title":"Midterm outcomes of transcatheter aortic valve replacement in patients with active cancer","volume":"11","author":"Noguchi","year":"2024","journal-title":"Open Heart"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jcin.2018.10.026","article-title":"Transcatheter Aortic Valve Replacement in Oncology Patients With Severe Aortic Stenosis","volume":"12","author":"Landes","year":"2019","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_18","first-page":"e73442","article-title":"Outcomes and Adverse Effects of Transcatheter Aortic Valve Replacement (TAVR) in Cancer Patients: A Meta-Analysis","volume":"16","author":"Ahsan","year":"2024","journal-title":"Cureus"},{"key":"ref_19","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jacc.2013.05.015","article-title":"Aortic stenosis in the elderly: Disease prevalence and number of candidates for transcatheter aortic valve replacement: A meta-analysis and modeling study","volume":"62","author":"Osnabrugge","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1056\/NEJMra1313875","article-title":"Aortic-valve stenosis--from patients at risk to severe valve obstruction","volume":"371","author":"Otto","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.2337\/dc10-0666","article-title":"Diabetes and cancer: A consensus report","volume":"33","author":"Giovannucci","year":"2010","journal-title":"Diabetes Care"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1158\/1055-9965.EPI-22-1170","article-title":"Serum Lipid Profiles and Cholesterol-Lowering Medication Use in Relation to Subsequent Risk of Colorectal Cancer in the UK Biobank Cohort","volume":"32","author":"Yuan","year":"2023","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1681\/ASN.2008090998","article-title":"Association of CKD and cancer risk in older people","volume":"20","author":"Wong","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1109034","article-title":"Genetic associations with valvular calcification and aortic stenosis","volume":"368","author":"Thanassoulis","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1093\/ndt\/gft310","article-title":"Aortic valve calcification in chronic kidney disease","volume":"28","author":"Rattazzi","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0735-1097(96)00563-3","article-title":"Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study","volume":"29","author":"Stewart","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"djv008","DOI":"10.1093\/jnci\/djv008","article-title":"Risk of valvular heart disease after treatment for Hodgkin lymphoma","volume":"107","author":"Cutter","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"100104","DOI":"10.1016\/j.shj.2022.100104","article-title":"Valvular Heart Disease Associated With Radiation Therapy: A Contemporary Review","volume":"7","author":"Lee","year":"2023","journal-title":"Struct. Heart J. Heart Team"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e021686","DOI":"10.1161\/JAHA.121.021686","article-title":"Radiation-Induced Cardiovascular Disease: Review of an Underrecognized Pathology","volume":"10","author":"Eisenberg","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1001\/jama.290.21.2831","article-title":"Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy","volume":"290","author":"Hull","year":"2003","journal-title":"JAMA"},{"key":"ref_33","first-page":"1508","article-title":"Transcatheter aortic valve intervention in patients with cancer","volume":"109","author":"Leedy","year":"2023","journal-title":"Heart (Br. Card. Soc.)"},{"key":"ref_34","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_35","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1200\/JCO.2005.03.8877","article-title":"Thromboembolism in hospitalized neutropenic cancer patients","volume":"24","author":"Khorana","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_38","first-page":"e35","article-title":"2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"595","DOI":"10.21037\/atm.2019.05.58","article-title":"Immunotherapy and targeted therapy-the new roadmap in cancer treatment","volume":"7","author":"Shahid","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nrc3237","article-title":"Combining immunotherapy and targeted therapies in cancer treatment","volume":"12","author":"Vanneman","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"100741","DOI":"10.1016\/j.clinsp.2025.100741","article-title":"Association of hematological malignancies with clinical and financial outcomes following transcatheter aortic valve replacement","volume":"80","author":"Liu","year":"2025","journal-title":"Clinics"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijcard.2020.03.038","article-title":"Favorable outcome of cancer patients undergoing transcatheter aortic valve replacement","volume":"315","author":"Biancari","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11886-019-1166-0","article-title":"The Onco-cardiologist Dilemma: To Implant, to Defer, or to Avoid Transcatheter Aortic Valve Replacement in Cancer Patients with Aortic Stenosis?","volume":"21","author":"Balanescu","year":"2019","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_44","first-page":"529","article-title":"Transcatheter aortic valve implantation in the presence of hematologic malignancies","volume":"43","author":"Ayhan","year":"2015","journal-title":"Turk. Kardiyol. Dern. Ars."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4244\/EIJ-D-23-01020","article-title":"Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: A VARC-HBR consensus document","volume":"20","author":"Garot","year":"2024","journal-title":"EuroIntervention"},{"key":"ref_46","first-page":"E202","article-title":"SCAI Expert consensus statement: Evaluation, management, and special considerations of cardio-oncology patients in the cardiac catheterization laboratory (endorsed by the cardiological society of india, and sociedad Latino Americana de Cardiolog\u0131a intervencionista)","volume":"87","author":"Iliescu","year":"2016","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.repc.2023.04.013","article-title":"Interventional cardiology in cancer patients: A position paper from the Portuguese Cardiovascular Intervention Association and the Portuguese Cardio-Oncology Study Group of the Portuguese Society of Cardiology","volume":"43","author":"Melica","year":"2024","journal-title":"Rev. Port. Cardiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.recesp.2019.02.015","article-title":"Percutaneous cardiological intervention and cardiac surgery: Patient-centered care. Position statement of the Spanish Society of Cardiology","volume":"72","author":"Cequier","year":"2019","journal-title":"Rev. Esp. Cardiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jaccao.2021.06.007","article-title":"Past, Present, and Future of Radiation-Induced Cardiotoxicity: Refinements in Targeting, Surveillance, and Risk Stratification","volume":"3","author":"Bergom","year":"2021","journal-title":"JACC Cardio Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.3109\/0284186X.2015.1016624","article-title":"Predicting radiation-induced valvular heart damage","volume":"54","author":"Cella","year":"2015","journal-title":"Acta Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40959-019-0044-7","article-title":"Clinical Outcomes after Transcatheter Aortic Valve Replacement in Cancer Survivors Treated with Ionizing Radiation","volume":"5","author":"Agrawal","year":"2019","journal-title":"Cardio-Oncology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40959-022-00133-2","article-title":"Mediastinal irradiation and valvular heart disease","volume":"8","author":"Patil","year":"2022","journal-title":"Cardio-Oncology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jaccao.2021.06.003","article-title":"Cardiovascular Manifestations from Therapeutic Radiation: A Multidisciplinary Expert Consensus Statement From the International Cardio-Oncology Society","volume":"3","author":"Mitchell","year":"2021","journal-title":"JACC Cardio Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.jaccas.2020.07.003","article-title":"Simultaneous Transcatheter Double Valve Treatment of Mediastinal Radiation-Induced Severe Calcific Aortic and Mitral Stenosis","volume":"2","author":"Allen","year":"2020","journal-title":"JACC Case Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1538-7836.2007.02497.x","article-title":"Cancer and thrombosis: From molecular mechanisms to clinical presentations","volume":"5","author":"Buller","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S0049-3848(09)70137-9","article-title":"Cancer-associated thrombosis: Risk factors, candidate biomarkers and a risk model","volume":"123","author":"Sud","year":"2009","journal-title":"Thromb. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1055\/s-0041-1733927","article-title":"Arterial Thrombosis in Cancer Patients: An Update","volume":"47","author":"Franchini","year":"2021","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_58","first-page":"2919","article-title":"Incidence, risk factors, and management of bleeding in patients receiving anticoagulants for the treatment of cancer-associated thrombosis","volume":"30","author":"Frere","year":"2022","journal-title":"Support. Care Cancer"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1093\/eurheartj\/ehab196","article-title":"Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: A consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart Disease","volume":"42","author":"Sibbing","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1136\/heartjnl-2018-314313","article-title":"Antithrombotic therapy in patients undergoing transcatheter aortic valve implantation","volume":"105","author":"Nijenhuis","year":"2019","journal-title":"Heart"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Cereda, A., Lucreziotti, S., Franchina, A.G., Laricchia, A., De Regibus, V., Conconi, B., Carl\u00e0, M., Spangaro, A., Rocchetti, M., and Ponti, L. (2023). Systematic Review and Meta-Analysis of Oral Anticoagulant Therapy in Atrial Fibrillation Cancer Patients. Cancers, 15.","DOI":"10.3390\/cancers15092574"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1593\/neo.04169","article-title":"Chemotherapy-induced and\/or radiation therapy-induced oral mucositis--complicating the treatment of cancer","volume":"6","author":"Naidu","year":"2004","journal-title":"Neoplasia"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e750","DOI":"10.1097\/HS9.0000000000000750","article-title":"EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer","volume":"6","author":"Falanga","year":"2022","journal-title":"Hemasphere"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1053\/j.seminoncol.2011.03.013","article-title":"Management of the cancer patient with infection and neutropenia","volume":"38","author":"Rapoport","year":"2011","journal-title":"Semin. Oncol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ccc.2020.09.001","article-title":"Infectious Disease Complications in Patients with Cancer","volume":"37","author":"Seo","year":"2021","journal-title":"Crit. Care Clin."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1093\/cid\/ciad431","article-title":"Patient Characteristics, Microbiology, and Mortality of Infective Endocarditis After Transcatheter Aortic Valve Implantation","volume":"77","author":"Strange","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jacc.2017.06.024","article-title":"Frailty in Older Adults Undergoing Aortic Valve Replacement: The FRAILTY-AVR Study","volume":"70","author":"Afilalo","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.amjcard.2015.03.061","article-title":"Relation of frailty to outcomes after transcatheter aortic valve replacement (from the PARTNER trial)","volume":"116","author":"Green","year":"2015","journal-title":"Am. J. Cardiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.6004\/jnccn.2015.0137","article-title":"Geriatric Assessment-Guided Care Processes for Older Adults: A Delphi Consensus of Geriatric Oncology Experts","volume":"13","author":"Mohile","year":"2015","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1200\/JCO.2013.54.8347","article-title":"International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer","volume":"32","author":"Wildiers","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jcin.2012.02.012","article-title":"Evaluation of multidimensional geriatric assessment as a predictor of mortality and cardiovascular events after transcatheter aortic valve implantation","volume":"5","author":"Stortecky","year":"2012","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/clc.23927","article-title":"Impact of frailty on mortality and quality of life in patients with a history of cancer undergoing transcatheter aortic valve replacement","volume":"45","author":"Kosaraju","year":"2022","journal-title":"Clin. Cardiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1161\/CIRCULATIONAHA.123.064071","article-title":"Sarcopenia and Cardiovascular Diseases","volume":"147","author":"Damluji","year":"2023","journal-title":"Circulation"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1002\/jcsm.13629","article-title":"Sarcopenia Is a Prognostic Factor of Adverse Effects and Mortality in Patients With Tumour: A Systematic Review and Meta-Analysis","volume":"15","author":"Zhang","year":"2024","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Ansaripour, A., Arjomandi Rad, A., Koulouroudias, M., Angouras, D., Athanasiou, T., and Kourliouros, A. (2023). Sarcopenia Adversely Affects Outcomes following Cardiac Surgery: A Systematic Review and Meta-Analysis. J. Clin. Med., 12.","DOI":"10.3390\/jcm12175573"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"5232480","DOI":"10.1155\/2022\/5232480","article-title":"Relation of Malnutrition and Nosocomical Infections in Cancer Patients in Hospital: An Observational Study","volume":"2022","author":"Muresan","year":"2022","journal-title":"J. Nutr. Metab."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12603-020-1448-7","article-title":"Sarcopenia in Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI): A Systematic Review of the Literature","volume":"25","author":"Bertschi","year":"2021","journal-title":"J. Nutr. Health Aging"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"105125","DOI":"10.1016\/j.archger.2023.105125","article-title":"Prognostic value of sarcopenia in older adults with transcatheter aortic valve implantation: A systematic review and meta-analysis","volume":"115","author":"Yang","year":"2023","journal-title":"Arch. Gerontol. Geriatr."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"He, J. (2025). Prognostic value of sarcopenia in aortic valve replacement: A systematic review and meta-analysis. Front. Nutr., 12.","DOI":"10.3389\/fnut.2025.1529270"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.amjcard.2016.05.052","article-title":"Comparison of Results of Transcatheter Aortic Valve Implantation in Patients With Versus Without Active Cancer","volume":"118","author":"Watanabe","year":"2016","journal-title":"Am. J. Cardiol."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Song, Y., Wang, Y., Wang, Z., Xu, C., Dou, J., and Jiang, T. (2022). Comparing Clinical Outcomes on Oncology Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.890082"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e030072","DOI":"10.1161\/JAHA.123.030072","article-title":"Transcatheter Aortic Valve Replacement in Patients With or Without Active Cancer","volume":"12","author":"Aikawa","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"ref_83","first-page":"101410","article-title":"Impact of cancer in patients with aortic stenosis undergoing transcatheter aortic valve replacement: A systematic review and meta-analysis","volume":"52","author":"Osawa","year":"2024","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e014248","DOI":"10.1161\/JAHA.119.014248","article-title":"Contemporary Trends and Outcomes of Percutaneous and Surgical Aortic Valve Replacement in Patients With Cancer","volume":"9","author":"Guha","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_85","first-page":"101045","article-title":"Prognosis of patients with active cancer undergoing transcatheter aortic valve implantation: An insight from Japanese multicenter registry","volume":"40","author":"Kojima","year":"2022","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Diaz-Arocutipa, C., Torres-Valencia, J., Zavaleta-Camacho, G., and Vicent, L. (2021). Association Between Previous or Active Cancer and Clinical Outcomes in TAVR Patients: A Systematic Review and Meta-Analysis of 255,840 Patients. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.763557"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jaccao.2020.11.008","article-title":"Impact of Cancer in Patients Undergoing Transcatheter Aortic Valve Replacement: A Single-Center Study","volume":"2","author":"Lind","year":"2020","journal-title":"JACC Cardio Oncol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.thromres.2023.05.012","article-title":"Anticoagulation management and related outcomes in patients with cancer-associated thrombosis and thrombocytopenia: A systematic review and meta-analysis","volume":"227","author":"Wang","year":"2023","journal-title":"Thromb. Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1161\/CIRCULATIONAHA.114.014089","article-title":"Infective endocarditis after transcatheter aortic valve implantation: Results from a large multicenter registry","volume":"131","author":"Eltchaninoff","year":"2015","journal-title":"Circulation"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/CRD.0000000000000460","article-title":"Infective Endocarditis After Transcatheter Aortic Valve Implantation: A Systematic Review","volume":"31","author":"Hassanin","year":"2023","journal-title":"Cardiol. Rev."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Khan, A., Aslam, A., Satti, K.N., and Ashiq, S. (2020). Infective endocarditis post-transcatheter aortic valve implantation (TAVI), microbiological profile and clinical outcomes: A systematic review. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0225077"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.amjcard.2022.02.049","article-title":"Characteristics and Outcomes After Transcatheter Aortic Valve Implantation in Immunocompromised Patients","volume":"173","author":"Ghannam","year":"2022","journal-title":"Am. J. Cardiol."},{"key":"ref_93","first-page":"157","article-title":"Transcatheter aortic valve replacement in patients with a history of cancer: Periprocedural and long-term outcomes","volume":"97","author":"Murphy","year":"2021","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_94","first-page":"8","article-title":"Outcomes after transcatheter aortic valve replacement in cancer survivors with prior chest radiation therapy: A systematic review and meta-analysis","volume":"6","author":"Zafar","year":"2020","journal-title":"Cardiooncology"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.carrev.2020.08.018","article-title":"Surgical Versus Transcatheter Aortic Valve Replacement in Patients With Malignancy","volume":"23","author":"Kadri","year":"2021","journal-title":"Cardiovasc. Revasc. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"734\u2013744; discussion 44\u201345","DOI":"10.1093\/ejcts\/ezs043","article-title":"EuroSCORE II","volume":"41","author":"Nashef","year":"2012","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.amjcard.2012.11.056","article-title":"Performance analysis of EuroSCORE II compared to the original logistic EuroSCORE and STS scores for predicting 30-day mortality after transcatheter aortic valve replacement","volume":"111","author":"Durand","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jaccao.2023.05.008","article-title":"Cardiac Interventions in Patients With Active, Advanced Solid and Hematologic Malignancies: JACC: CardioOncology State-of-the-Art Review","volume":"5","author":"Leong","year":"2023","journal-title":"JACC Cardio Oncol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ahj.2010.05.038","article-title":"Quality of life among patients undergoing transcatheter aortic valve implantation","volume":"160","author":"Krane","year":"2010","journal-title":"Am. Heart J."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/1474515114520770","article-title":"Integrating a palliative approach in a transcatheter heart valve program: Bridging innovations in the management of severe aortic stenosis and best end-of-life practice","volume":"13","author":"Lauck","year":"2014","journal-title":"Eur. J. Cardiovasc. Nurs."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/ehjcvp\/pvad101","article-title":"Antithrombotic therapy in patients after transcatheter aortic valve implantation: A network meta-analysis","volume":"10","author":"Turgeon","year":"2024","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"ezae461","DOI":"10.1093\/ejcts\/ezae461","article-title":"The current state of the multidisciplinary heart team approach: A systematic review","volume":"67","author":"Streukens","year":"2024","journal-title":"Eur. J. Cardiothorac. Surg."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/6\/1139\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T07:46:18Z","timestamp":1781163978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/6\/1139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":102,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["medicina62061139"],"URL":"https:\/\/doi.org\/10.3390\/medicina62061139","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]}}}